← Open Payments lookup

ANTHONY SANTOS: Open Payments

NPI 1750610168 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,633 in 94 payments from 10 companies in 2025. Trend: 2023 $1,727 · 2024 $1,592 · 2025 $6,633

Speaker / faculty: $2,880Food & beverage: $2,047Travel & lodging: $946Consulting: $760
CompanyPaymentsAmount
Gilead Sciences, Inc.22$4,538
Intercept Pharmaceuticals, Inc.1$760
Madrigal Pharmaceuticals22$459
Salix Pharmaceuticals, a division of Bausch Health US, LLC20$330
ABBVIE INC.12$174
Ipsen Biopharmaceuticals, Inc7$145
Novo Nordisk Inc6$117
ORPHALAN INC2$57
Boehringer Ingelheim Pharmaceuticals, Inc.1$30
Fujifilm Healthcare Americas Corporation1$23

Products named: Livdelzi, OCALIVA, REZDIFFRA, XIFAXAN, IQIRVO, Wegovy, MAVYRET, CREON.

Industry payments across TX — which companies pay providers there.